Powles T, et al. A phase II study investigating the safety and efficacy of savolitinib and durvalumab in metastatic papillary renal cancer (CALYPSO). ASCO-GU 2019, abstract 545.
Darmkanker vaker ontdekt in vroeg stadium, minder operaties en betere overleving
mrt 2024 | Maag-darm-leveroncologie